New Hepatitis-C drug raises hope at a hefty price

Aired: 4/23/2014 | 0:07:36 | Clip
A new drug has a 90 to 100 percent chance of curing the Hepatitis C virus, but costs tens of thousands of dollars for a course of treatment. The announcement by the manufacturer that it earned more than $2 billion in the year’s first quarter raises the question, who should pay when drugs are highly effective, but extremely expensive? Hari Sreenivasan reports on the profits, coverage and costs.